Experimental
Methods in MR of Cancer
Martin O. Leach, Anwar Padhani, Organizers
Sunday 7 May, 08:30 - 17:15
Overview:
This one-day course aims to provide an introduction to and outline of developing
MR techniques for non-invasively, experimentally or clinically assessing the
effects of molecular processes contributing to or controlling the development of
cancer. MR measurement methods will be described and explained in the context of
these molecular processes, together with associated laboratory or clinical
methods for directly evaluating or inhibiting cellular processes or genotype.
These approaches are relevant to diagnosis, assessment of tumor grade, and
likelihood of metastatic spread, and to the pre-clinical and clinical assessment
of novel anti-cancer therapies.
Educational Objectives:
Upon completion of this session participants should be able to:
• Describe how MRS can demonstrate upregulation or inhibition of important
pathways in cancer, in cell and xenograft models;
• Explain the role of choline in cellular metabolism, what MRS shows and how it
may be affected by the cancer phenotype and treatment;
• List clinical applications of MR spectroscopy;
• Describe how contrast agents can be used to evaluate vascular function, and
how physiological and other modelling parameters can be derived by the use of
models;
• Explain the use of intrinsic contrast mechanisms to evaluate vascular
function;
• Describe hypoxia in the context of cancer, identifying methods of assessing
hypoxia using MR;
• Describe clinical applications relating to tumor vascular support;
• Describe how MAS can be used to assess tumors;
• Identify the likely MR changes resulting from apoptosis; and
• Describe how diffusion measurements can provide information on cancer in
experimental models and in patients, and how diffusion may change with
treatment.
Audience Description:
This course is designed for those with degree level education in physical,
biological or medical sciences, an interest in cancer, and whose current work
may be in research training, practice, or clinical training or practice. No
special experience is required.
I Cellular Pathways and Processes as Cancer Targets | |||
8:30 | Evaluating Pathways, Inhibition and Regulation Using MRS | Sabrina M. Ronen, Ph.D. | |
9:00 | Choline Metabolism: Meaning and Significance | Hadassa Degani, Ph.D. | |
9:30 | Clinical applications of magnetic resonance spectroscopy | Arend Heerschap, Ph.D. | |
10:00 | Break - Meet the Teachers | ||
II Tumor Vasculature in Development and Treatment | |||
10:30 | Measuring Vascular Properties Using Contrast Agents | Martin O. Leach, Ph.D. | |
11:00 | Tracer Kinetic Models: Extracting Physiological Vascular | David L. Buckley, Ph.D. | |
Information | |||
11:30 | Measuring Vascular Properties Using Intrinsic Contrast | Gregory S. Karczmar, Ph.D. | |
Mechanisms (inc BOLD) | |||
12:00 | Break | ||
12:00 - 12:15 - Meet the Teachers | |||
13:30 | Hypoxia and Its Assessment | Ralph P. Mason, Ph.D. | |
14:00 | Clinical applications of MR methods that assess | Anwar Padhani, M.R.C.P., F.R.C.R. | |
tumor vascular functionality | |||
III New Methods for Diagnosis and Evaluation | |||
14:30 | Associating MR Findings with MR Gene and Protein | Samira Guccione, Ph.D. | |
Expression | |||
15:00 | Break - Meet the Teachers | ||
15:30 | Diagnosis of Cancer Using MAS | Ingrid S. Gribbestad, Ph.D | |
16:00 | Apoptosis: MR Consequences | Risto A. Kauppinen, M.D., Ph.D. | |
16:30 | Diffusion MRI: A biomarker for cancer treatment response | Brian D. Ross, Ph.D. | |
17:00 | Adjournment | ||
17:00 - 17:15 - Meet the Teachers |